Cabot (NYSE:CBT) Reaches New 1-Year High – Here’s Why

22 Jun 2026, 14:01 by Mitch Edgeman · The Markets Daily

Cabot Corporation (NYSE:CBT – Get Free Report)’s share price reached a new 52-week high during trading on Monday . The company traded as high as $91.80 and last traded at $91.0750, with a volume of 1456587 shares trading hands. The stock had previously closed at $91.80.

Analyst Upgrades and Downgrades

CBT has been the topic of a number of research analyst reports. JPMorgan Chase & Co. boosted their price target on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Mizuho lifted their target price on shares of Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. UBS Group boosted their target price on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Finally, Truist Financial began coverage on shares of Cabot in a research note on Monday, June 8th. They set a “buy” rating and a $98.00 price target on the stock. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $83.80.

View Our Latest Analysis on Cabot

Cabot Trading Down 0.2%

The stock has a 50-day moving average of $81.52 and a 200 day moving average of $74.87. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The stock has a market cap of $4.73 billion, a PE ratio of 17.33, a price-to-earnings-growth ratio of 12.07 and a beta of 0.82.

Cabot (NYSE:CBT – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The company had revenue of $904.00 million during the quarter, compared to analyst estimates of $900.30 million. During the same period last year, the firm posted $1.90 EPS. Cabot’s revenue for the quarter was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, sell-side analysts anticipate that Cabot Corporation will post 6.34 earnings per share for the current year.

Cabot Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were issued a dividend of $0.4725 per share. This represents a $1.89 annualized dividend and a dividend yield of 2.1%. This is a boost from Cabot’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend was Friday, May 29th. Cabot’s dividend payout ratio is 35.73%.

Institutional Investors Weigh In On Cabot

Several hedge funds have recently added to or reduced their stakes in CBT. Torren Management LLC acquired a new position in shares of Cabot in the 4th quarter valued at about $26,000. Rothschild Investment LLC lifted its holdings in Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 259 shares during the period. Global Retirement Partners LLC boosted its position in Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after purchasing an additional 466 shares in the last quarter. Geneos Wealth Management Inc. grew its stake in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. Finally, Danske Bank A S purchased a new position in shares of Cabot during the 3rd quarter valued at approximately $38,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

About Cabot

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.